Skip to main navigation Skip to search Skip to main content

Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial

  • Stefan D. Anker
  • , Stephan von Haehling
  • , Joerg C. Schefold
  • , Ewa A. Jankowska
  • , Jochen Springer
  • , Ali Vazir
  • , Paul R. Kalra
  • , Anja Sandek
  • , Günter Fauler
  • , Tatjana Stojakovic
  • , Michael Trauner
  • , Piotr Ponikowski
  • , Hans-Dieter Volk
  • , Wolfram Doehner
  • , Andrew J.S. Coats
  • , Philip A. Poole-Wilson

Research output: Contribution to journalArticlepeer-review

76 Citations (Scopus)

Abstract

This study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF).
Original languageEnglish
Pages (from-to)585-592
JournalJournal of the American College of Cardiology
Volume59
Issue number6
DOIs
Publication statusPublished - 7 Feb 2012

Keywords

  • Heart failure

Fingerprint

Dive into the research topics of 'Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial'. Together they form a unique fingerprint.

Cite this